Adenoviral gene transfer holds promise for gene therapy, but effective tran
sduction of id large and distributed tissue such as muscle will almost cert
ainly require systemic delivery. In this context, the use of muscle-specifi
c regulatory elements such as the muscle creatine kinase (MCK) promoter and
enhancer will avoid potentially harmful ectopic expression of transgenes.
We describe here the development and testing of adenoviral vectors containi
ng small, striated muscle-specific, highly active MCK expression cassettes.
One of these regulatory elements (CK6) is less than 600 bp in length and i
s 12% as active as the CMV promoter/enhancer in muscle. A recombinant adeno
viral vector containing this regulatory element retains very high muscle sp
ecificity, expressing 600-fold higher levels of transgene in muscle than in
liver. Muscle-specific regulatory elements may also increase persistence o
f transduced muscle cells. Adenoviral transduction of dendritic cells has b
een shown to stimulate cytotoxic T-lymphocyte (CTL) responses directed agai
nst transgene epitopes. We show that human dendritic cells infected in vitr
o with MCK-containing adenoviruses do not express significant levels of tra
nsgene. Furthermore, while adenoviral vectors containing nonspecific promot
ers are normally cleared from muscle tissue within 1 month, we show that MC
K-containing vectors express significant levels of transgene 4 months after
intramuscular injection.